ASTRAZENECA AND MITSUBISHI TANABE PHARMA CORPORATION ANNOUNCE RESEARCH COLLABORATION IN DIABETIC NEPHROPATHY

AstraZeneca and Mitsubishi Tanabe Pharma Corporation (MTPC) today announce a three-year research collaboration in the area of diabetic nephropathy. The aim of the research collaboration is to leverage complementary strengths, expertise and assets to validate and progress novel research targets and molecules into clinical development.The collaboration will span from target selection up to the delivery of small molecule candidate drugs. Targets from each company’s early research portfolios have been identified as approaches of common interest and additional targets may be included under the